On June 17, 2020 Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, reported new information regarding its participation in two upcoming investor virtual conferences. Gerald McMahon, Ph.D., President and Chief Executive Officer, will now participate in (Press release, Harpoon Therapeutics, JUN 17, 2020, View Source [SID1234561190]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A fireside chat at the JMP Securities Hematology & Oncology Forum on Thursday, June 18, 2020 at 3:40 p.m. ET / 12:40 p.m. PT (revised time); and

A presentation (revised format) at the BMO 2020 Prescriptions for Success Healthcare Conference on Tuesday, June 23, 2020 at 2:30 p.m. ET / 11:30 a.m. PT.
A live audio webcast of the fireside chat and presentation will be available in the Investors section of Harpoon Therapeutics’ website at www.harpoontx.com.